CircMCTP2 (has-circ-0000658) facilitates the proliferation and metastasis of bladder carcinoma through modulating the miR-498/murine double minute-2 axis

References

• Sanli O, Dobruch J, Knowles MA, et al. Bladder cancer. Nat Rev Dis Primers. 2017;3:17022.
   PubMed Web of Science ®Google Scholar
• Antoni S, Ferlay J, Soerjomataram I, et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96–108.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Alifrangis C, McGovern U, Freeman A, et al. Molecular and histopathology directed therapy for advanced bladder cancer. Nat Rev Urol. 2019;16(8):465–483.
   PubMed Web of Science ®Google Scholar
• Witjes JA, Bruins HM, Cathomas R, et al. European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol. 2021;79(1):82–104.
   PubMed Web of Science ®Google Scholar
• Patop IL, Wust S, Kadener S. Past, present, and future of circRNAs. EMBO J. 2019;38(16):e100836.
   PubMed Web of Science ®Google Scholar
• Rybak-Wolf A, Stottmeister C, Glazar P, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell. 2015;58(5):870–885.
   PubMed Web of Science ®Google Scholar
• Li J, Huang C, Zou Y, et al. CircTLK1 promotes the proliferation and metastasis of renal cell carcinoma by sponging miR-136-5p. Mol Cancer. 2020;19(1):103.
   PubMed Web of Science ®Google Scholar
• Chia W, Liu J, Huang YG, et al. A circular RNA derived from DAB1 promotes cell proliferation and osteogenic differentiation of BMSCs via RBPJ/DAB1 axis. Cell Death Dis. 2020;11(5):372.
   PubMed Web of Science ®Google Scholar
• Xu JY, Chang NB, Rong ZH, et al. circDiaph3 regulates rat vascular smooth muscle cell differentiation, proliferation, and migration. FASEB J. 2019;33(2):2659–2668.
   PubMed Web of Science ®Google Scholar
• Han N, Ding L, Wei X, et al. circSMAD2 governs migration and epithelial-mesenchymal transition by inhibiting microRNA-9. J Cell Biochem. 2019. DOI:10.1002/jcb.29638.
   Google Scholar
• Li M, Ding W, Sun T, et al. Biogenesis of circular RNAs and their roles in cardiovascular development and pathology. FEBS J. 2018;285(2):220–232.
   PubMed Web of Science ®Google Scholar
• Shan K, Liu C, Liu BH, et al. Circular noncoding RNA HIPK3 mediates retinal vascular dysfunction in diabetes mellitus. Circulation. 2017;136(17):1629–1642.
   PubMed Web of Science ®Google Scholar
• Li J, Huang C, Zou Y, et al. Circular RNA MYLK promotes tumour growth and metastasis via modulating miR-513a-5p/VEGFC signalling in renal cell carcinoma. J Cell Mol Med. 2020;24(12):6609–6621.
   PubMed Web of Science ®Google Scholar
• Jin X, Xu Y, Guo M, et al. hsa_circNFXL1_009 modulates apoptosis, proliferation, migration, and potassium channel activation in pulmonary hypertension. Mol Ther Nucleic Acids. 2021;23:1007–1019.
   PubMedGoogle Scholar
• Tong L, Yang H, Xiong W, et al. circ_100984-miR-432-3p axis regulated c-Jun/YBX-1/beta-catenin feedback loop promotes bladder cancer progression. Cancer Sci. 2021;112(4):1429–1442.
   PubMed Web of Science ®Google Scholar
• Cao G, Zhang C, Tian X, et al. circCEP128 knockdown suppresses bladder cancer progression via regulating microRNA-515-5p/SDC1 axis. Cancer Manag Res. 2021;13:2885–2896.
   PubMed Web of Science ®Google Scholar
• Ye W, Chen L, Feng C, et al. CircMYLK promotes the growth, migration, invasion, and survival of bladder cancer cells by upregulating CCND3 level via competitively binding to miR-34a. Drug Dev Res. 2021;82(8):1206–1216.
   PubMed Web of Science ®Google Scholar
• Yang J, Liu X, Dai G, et al. CircNT5E promotes the proliferation and migration of bladder cancer via sponging miR-502-5p. J Cancer. 2021;12(8):2430–2439.
   PubMed Web of Science ®Google Scholar
• Yao J, Qian K, Chen C, et al. ZNF139/circZNF139 promotes cell proliferation, migration and invasion via activation of PI3K/AKT pathway in bladder cancer. Aging (Albany NY). 2020;12(10):9915–9934.
   PubMedGoogle Scholar
• Sun G, Li Z, He Z, et al. Circular RNA MCTP2 inhibits cisplatin resistance in gastric cancer by miR-99a-5p-mediated induction of MTMR3 expression. J Exp Clin Cancer Res. 2020;39(1):246.
   PubMed Web of Science ®Google Scholar
• Thomson DW, Dinger ME. Endogenous microRNA sponges: evidence and controversy. Nat Rev Genet. 2016;17(5):272–283.
   PubMed Web of Science ®Google Scholar
• Catto JW, Alcaraz A, Bjartell AS, et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur Urol. 2011;59(5):671–681.
   PubMed Web of Science ®Google Scholar
• Lv S, Li Y, Ning H, et al. CircRNA GFRA1 promotes hepatocellular carcinoma progression by modulating the miR-498/NAP1L3 axis. Sci Rep. 2021;11(1):386.
   PubMed Web of Science ®Google Scholar
• Chen D, Li Y, Wang Y, et al. LncRNA HOTAIRM1 knockdown inhibits cell glycolysis metabolism and tumor progression by miR-498/ABCE1 axis in non-small cell lung cancer. Genes Genomics. 2021;43(2):183–194.
   PubMed Web of Science ®Google Scholar
• Liu C, Zhang W, Xing W, et al. MicroRNA-498 disturbs the occurrence and aggression of colon cancer through targeting MDM2 to mediate PPARgamma ubiquitination. Life Sci. 2021;277:119225.
   PubMed Web of Science ®Google Scholar
• Philippe GJ, Mittermeier A, Lawrence N, et al. Angler peptides: macrocyclic conjugates inhibit p53:MDM2/X interactions and activate apoptosis in cancer cells. ACS Chem Biol. 2021;16(2):414–428.
   PubMed Web of Science ®Google Scholar
• Ladanyi M, Cha C, Lewis R, et al. MDM2 gene amplification in metastatic osteosarcoma. Cancer Res. 1993;53(1):16–18.
   PubMed Web of Science ®Google Scholar
• Liu J, Wu D, Lin X, et al. Long non-coding RNA TUG1 sponges microRNA-381-3p to facilitate cell viability and attenuate apoptosis in cervical cancer by elevating MDM2 expression. Life Sci. 2021;267:118902.
   PubMed Web of Science ®Google Scholar
• Ma W, Zhao P, Zang L, et al. CircTP53 promotes the proliferation of thyroid cancer via targeting miR-1233-3p/MDM2 axis. J Endocrinol Invest. 2021;44(2):353–362.
   PubMed Web of Science ®Google Scholar
• Wang QS, Zhou J, Li X. LncRNA UCA1 protects cardiomyocytes against hypoxia/reoxygenation induced apoptosis through inhibiting miR-143/MDM2/p53 axis. Genomics. 2020;112(1):574–580.
   PubMed Web of Science ®Google Scholar
• Konopleva M, Martinelli G, Daver N, et al. MDM2 inhibition: an important step forward in cancer therapy. Leukemia. 2020;34(11):2858–2874.
   PubMed Web of Science ®Google Scholar
• Wu C, Li Z, Feng G, et al. Tumor suppressing role of serum-derived exosomal microRNA-15a in osteosarcoma cells through the GATA binding protein 2/murine double minute 2 axis and the p53 signaling pathway. Bioengineered. 2021;12(1):8378–8395.
   PubMed Web of Science ®Google Scholar
• Mao M, Yang L, Hu J, et al. OCT3/4 enhances tumor immune response by upregulating the TET1-dependent NRF2/MDM2 axis in bladder cancer. Genomics. 2021;113(4):2122–2133.
   PubMed Web of Science ®Google Scholar
• Luo KW, Zhu XH, Zhao T, et al. EGCG enhanced the anti-tumor effect of doxorubicine in bladder cancer via NF-kappaB/MDM2/p53 pathway. Front Cell Dev Biol. 2020;8:606123.
   PubMed Web of Science ®Google Scholar
• Wu D, Niu X, Tao J, et al. MicroRNA-379-5p plays a tumor-suppressive role in human bladder cancer growth and metastasis by directly targeting MDM2. Oncol Rep. 2017;37(6):3502–3508.
   PubMed Web of Science ®Google Scholar
• Zhang M, Xu Y, Yin S, et al. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1. Bioengineered. 2021;12(2):9150–9161.
   PubMed Web of Science ®Google Scholar
• Du W, Li D, Guo X, et al. Circ-PRMT5 promotes gastric cancer progression by sponging miR-145 and miR-1304 to upregulate MYC. Artif Cells Nanomed Biotechnol. 2019;47(1):4120–4130.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Cao W, Wu K, et al. LncRNA LINC00460 promotes EMT in head and neck squamous cell carcinoma by facilitating peroxiredoxin-1 into the nucleus. J Exp Clin Cancer Res. 2019;38(1):365.
   PubMed Web of Science ®Google Scholar
• Zhu X, Shao P, Tang Y, et al. hsa_circRNA_100533 regulates GNAS by sponging hsa_miR_933 to prevent oral squamous cell carcinoma. J Cell Biochem. 2019;120(11):19159–19171.
   PubMed Web of Science ®Google Scholar
• Fu Y, Hu X, Gao Y, et al. LncRNA ROR/miR-145-5p axis modulates the osteoblasts proliferation and apoptosis in osteoporosis. Bioengineered. 2021;12(1):7714–7723.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li K, Zou X, et al. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis. Bioengineered. 2021;12(2):10862–10877.
   PubMed Web of Science ®Google Scholar
• Livingston JA. How to control accounts receivable without them controlling you. Dent Assist (Waco Tx). 1986;5(5):8–9.
   PubMedGoogle Scholar
• Zhang Q, Wang Z, Cheng X, et al. lncRNA DANCR promotes the migration an invasion and of trophoblast cells through microRNA-214-5p in preeclampsia. Bioengineered. 2021;12(2):9424–9434.
   PubMed Web of Science ®Google Scholar
• Song Z, Wang J. LncRNA ASMTL-AS1/microRNA-1270 differentiate prognostic groups in gastric cancer and influence cell proliferation, migration and invasion. Bioengineered. 2022;13(1):1507–1517.
   PubMed Web of Science ®Google Scholar
• Tang D, Geng L, Ma J. lncRNA PROX1-AS1 mediates the migration and invasion of placental trophoblast cells via the miR-211-5p/caspase-9 axis. Bioengineered. 2021;12(1):4100–4110.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yang Y, Zhou C, et al. LncRNA miR-17-92a-1 cluster host gene (MIR17HG) promotes neuronal damage and microglial activation by targeting the microRNA-153-3p/alpha-synuclein axis in Parkinson’s disease. Bioengineered. 2022;13(2):4493–4516.
   PubMed Web of Science ®Google Scholar
• Sang Y, Chen B, Song X, et al. circRNA_0025202 regulates tamoxifen sensitivity and tumor progression via regulating the miR-182-5p/FOXO3a axis in breast cancer. Mol Ther. 2019;27(9):1638–1652.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yao T, Ni H, et al. Circular RNA circSIPA1L1 contributes to osteosarcoma progression through the miR-411-5p/RAB9A signaling pathway. Front Cell Dev Biol. 2021;9:642605.
   PubMed Web of Science ®Google Scholar
• Nadal R, Bellmunt J. Management of metastatic bladder cancer. Cancer Treat Rev. 2019;76:10–21.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, et al. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33.
   PubMed Web of Science ®Google Scholar
• Vetterlein MW, Witjes JA, Loriot Y, et al. Cutting-edge management of muscle-invasive bladder cancer in 2020 and a glimpse into the future. Eur Urol Oncol. 2020;3(6):789–801.
   PubMed Web of Science ®Google Scholar
• Cong L, Yang Q, Hu C, et al. Current status of functional studies on circular RNAS in bladder cancer and their potential role as diagnostic and prognostic biomarkers: a review. Med Sci Monit. 2019;25:3425–3434.
   PubMed Web of Science ®Google Scholar
• Xiong DD, Dang YW, Lin P, et al. A circRNA-miRNA-mRNA network identification for exploring underlying pathogenesis and therapy strategy of hepatocellular carcinoma. J Transl Med. 2018;16(1):220.
   PubMed Web of Science ®Google Scholar
• Liang ZZ, Guo C, Zou MM, et al. circRNA-miRNA-mRNA regulatory network in human lung cancer: an update. Cancer Cell Int. 2020;20(1):173.
   PubMed Web of Science ®Google Scholar
• Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, et al. An overview of microRNAs: biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019;234(5):5451–5465.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Dai B, Zhang H, et al. Long non-coding RNA LOC572558 inhibits bladder cancer cell proliferation and tumor growth by regulating the AKT-MDM2-p53 signaling axis. Cancer Lett. 2016;380(2):369–374.
   PubMed Web of Science ®Google Scholar
• Hitzenbichler F, Stoehr CG, Rogenhofer M, et al. Mdm2 SNP309 G-variant is associated with invasive growth of human urinary bladder cancer. Pathobiology. 2014;81(2):53–59.
   PubMed Web of Science ®Google Scholar